AngioDynamics, Inc. carries no debt; cash flow comfortably covers obligations.

AngioDynamics, Inc.'s free cash flow has increased -56.99% from $-33.93M last year to $-14.59M, signaling increasing performance

AngioDynamics, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

AngioDynamics, Inc.'s debt has decreased relative to shareholder equity from 0.06 last year to 0.00 today, signaling strengthened financials

AngioDynamics, Inc. has a net cash position, so leverage is healthy.

AngioDynamics, Inc. carries no debt; interest obligations are fully covered.

AngioDynamics, Inc.'s profit margin has increased (-1.26%) in the last year from -11.62% to -11.48%, signaling increasing performance

AngioDynamics, Inc.'s short-term assets of $163.39M exceed its short-term liabilities of $74.72M

AngioDynamics, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

AngioDynamics, Inc.'s return on equity of -21.01%, is lower than 15.00%, indicating bad performance

AngioDynamics, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

AngioDynamics, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

AngioDynamics, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

AngioDynamics, Inc. has negative free cash flow, indicating cash burn

AngioDynamics, Inc.'s yearly earnings has decreased 8.09% since last year from $-33.99M to $-36.74M, signaling decreasing performance

AngioDynamics, Inc.'s yearly revenue has increased 9.46% since last year from $292.50M to $320.17M, signaling increasing performance

ROIC -20.75% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

AngioDynamics, Inc.'s 3-year revenue CAGR of -1.86% is negative, indicating declining revenue over the past 3 years

AngioDynamics, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

AngioDynamics, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

AngioDynamics, Inc. has insufficient data to evaluate this check.

AngioDynamics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

AngioDynamics, Inc. is overvalued relative to its fair value price of 1.65 based on EBITDA multiple model

AngioDynamics, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

AngioDynamics, Inc. is overvalued relative to its fair value price of -10.28 based on Earnings Fair Value model

AngioDynamics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

AngioDynamics, Inc. has a price-to-book ratio of 3.83x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

AngioDynamics, Inc. has a price-to-sales ratio of 2.04x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue